|Articles|December 1, 2018
- Pharmaceutical Executive-12-01-2018
- Volume 38
- Issue 12
Pharmaceutical Executive, December 2018 Issue (PDF)
Click the title above to open the Pharmaceutical December 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Science & Finance: The Biotech Blendabout 7 years ago
Europe’s Digital Health Path Still at a Crossroadsabout 7 years ago
Lessons for Pharma from the Merck Cyber Attackabout 7 years ago
Securing a Winning Strategy for Real-World Evidenceabout 7 years ago
RWE: Answering Questions in Rare Diseaseabout 7 years ago
Measuring the Probability of Pricing and Access Successabout 7 years ago
Four Challenges for AI in the Life Sciencesabout 7 years ago
Country Report: MalaysiaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Nimbus Therapeutics and Eli Lilly Enter $1.3 Billion License Agreement and Research Collaboration for Oral Obesity Treatments
2
Novo Nordisk’s Wegovy Pill Becomes First Oral GLP-1 Available in U.S.
3
Amgen Acquires Dark Blue Therapeutics in $840 Million Transaction
4
The Real Value Equation: How Humans and AI Create and Destroy Value in Pharma
5